Margaret E. Whicker
Obstetrics and Gynecology
1851 N George Mason Dr Fl Fifth
Arlington, VA 22207
Arlington, VA 22207
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer.
Journal: Research square
Published: October 16, 2023
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2023
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
Journal: Cancer
Published: August 24, 2020
Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes.
Journal: Gynecologic and obstetric investigation
Published: April 10, 2018
Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer.
Journal: Gynecologic oncology reports
Published: October 24, 2017
The management of sexuality, intimacy, and menopause symptoms (SIMS) after prophylactic bilateral salpingo-oophorectomy: How to maintain sexual health in "previvors".
Journal: Maturitas
Published: March 30, 2017
Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer.
Journal: American journal of obstetrics and gynecology
Published: February 09, 2017
Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair.
Journal: British journal of cancer
Published: February 06, 2016
MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
Journal: BMC cancer
Published: January 22, 2016
Triapine disrupts CtIP-mediated homologous recombination repair and sensitizes ovarian cancer cells to PARP and topoisomerase inhibitors.
Journal: Molecular cancer research : MCR
Published: January 14, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026